| 07.05 13:32 | dpa-AFX: Perrigo Q1 24 Earnings Conference Call At 8:30 AM ET |
| 07.05 12:51 | dpa-AFX: ROUNDUP: Perrigo Reaffirms 2024 Outlook |
| 07.05 12:37 | dpa-AFX: *PERRIGO REAFFIRMS 2024 ADJ. EPS OUTLOOK OF $2.50-$2.65 |
| 07.05 12:36 | dpa-AFX: *PERRIGO REAFFIRMS 2024 ORGANIC NET SALES AND TOTAL NET SALES GROWTH OUTLOOK OF 1.0%-3.0% |
| 07.05 12:36 | dpa-AFX: *PERRIGO Q1 NET INCOME $2 MLN VS LOSS $3 MLN PRIOR YEAR |
| 07.05 12:35 | dpa-AFX: *PERRIGO Q1 EPS $0.03 VS LOSS/SHR $0.01 PRIOR YEAR |
| 07.05 12:35 | dpa-AFX: Perrigo Company plc Q1 Earnings Summary |
| 07.05 12:33 | dpa-AFX: *PERRIGO Q1 ADJ.EPS $0.29 VS $0.45 IN PRIOR YEAR QUARTER |
| 07.05 12:32 | dpa-AFX: *PERRIGO Q1 NET SALES $1.1 BLN, DECLINE OF 8.4% FROM PRIOR YEAR QUARTER |
| 07.05 12:30 | dpa-AFX: *PERRIGO : SVEND ANDERSEN, EVP AND PRESIDENT CONSUMER SELF-CARE INTERNATIONAL, TO RETIRE |
| 01.05 15:47 | dpa-AFX: *PERRIGO COMPANY PLC (PRGO) DECLARES QUARTERLY DIVIDEND OF $ 0.276, RECORD DATE 5/31/2024 |
| 01.05 15:44 | dpa-AFX: *PERRIGO DECLARES QUARTERLY DIVIDEND OF $0.276/SHR; PAYABLE JUNE 18/ RECORD MAY 31 |
| 25.04 12:35 | dpa-AFX: Esteve Healthcare To Buy Perrigo's HRA Pharma Rare Diseases Business For Up To EUR 275 Mln |
| 25.04 12:02 | dpa-AFX: *PERRIGO SEES HRA PHARMA RARE DISEASES BUSINESS TRANSACTION TO CLOSE DURING Q3 OF 2024 |
| 25.04 12:01 | dpa-AFX: *PERRIGO RECEIVES BINDING OFFER TO DIVEST HRA PHARMA RARE DISEASES BUSINESS FOR UP TO EUR 275 MLN |
| 04.03 14:47 | dpa-AFX: Perrigo Initiates Shipments Of Opill To Retailers Nationwide |
| 04.03 14:03 | dpa-AFX: *PERRIGO COMMENCES SHIPMENTS OF OPILL TO RETAILERS NATIONWIDE |
| 27.02 14:14 | dpa-AFX: ROUNDUP: Perrigo Launches Project Energize To Improve Efficiency, Cut Costs; To Cut 6% Jobs |
| 27.02 13:31 | dpa-AFX: Perrigo Q4 23 Earnings Conference Call At 8:30 AM ET |
| 27.02 12:48 | dpa-AFX: ROUNDUP: Perrigo Guides FY24 Well Below Estimates |
|
|
